_id

69105755ccc777a4e85d567e

Ticker

CVAC

Name

CureVac NV

Exchange

NASDAQ

Address

Friedrich-Miescher-Strasse 15, Tübingen, Germany, 72076

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.curevac.com

Description

CureVac N.V., a biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). The company's portfolio includes clinical and preclinical candidates for various disease indications in prophylactic vaccines, oncology, and molecular therapy. It also delivers optimized mRNAs to stimulate the production of therapeutic proteins utilizing its technology and instructs human cells to produce or secrete specific proteins in the nucleus, cytoplasm, cellular organelles, and cell membrane. In addition, the company offers The RNA Printer, a downsized, integrated, and highly automated process for manufacturing of mRNA vaccines and therapeutics. Further, it develops prophylactic vaccine lead candidate that addresses urinary tract infections targeting uropathogenic E. coli (UPEC) bacteria; vaccine candidates CV0601 and CV0701, which are in phase 2 clinical study against SARS-CoV-2; vaccines for off-the-shelf and fully personalized cancer precision immunotherapies in oncology; and CVGBM for treating cancer. Additionally, the company develops, manufactures, and commercializes mRNA vaccines targeting SARS-CoV-2 variants; antigen cancer precision immunotherapy candidate that targets squamous non-small cell lung cancer; and antigen cancer precision immunotherapy candidate CVGBM that is tested in patients with surgically resected MGMT-unmethylated glioblastoma or astrocytoma with a molecular signature of glioblastoma. CureVac N.V. was founded in 2000 and is headquartered in Tübingen, Germany.

Last Close

5.12

Volume

5372046

Current Price

5.05

Change

-1.3671875000000056

Last Updated

2025-11-29T12:00:46.500Z

Image

data:image/webp;base64,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

Ipo Date

2020-08-14T00:00:00.000Z

Market Cap

1236198400

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.5309230769230768

Sentiment Sources

13

Rating

3.6667

Target Price

5.3467

Strong Buy

2

Buy

0

Hold

4

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

493902000

Cost Of Revenue

-21931000

Gross Profit

472971000

Operating Expenses

-32612000

Operating Income

368379000

Interest Expense

141000

Pretax Income

370572000

Net Income

338043000

Eps

1.5012607053973481

Dividends Per Share

-

Shares Outstanding

225172749

Income Tax Expense

-32529000

EBITDA

-

Operating Margin

74.58544407595029

Total Other Income Expense Net

-35377000

Cash

416090000

Short Term Investments

3123000

Receivables

19599000

Inventories

541000

Total Current Assets

873111000

Property Plant Equipment

235603000

Total Assets

1138619000

Payables

8715000

Short Term Debt

-

Long Term Debt

-

Total Liabilities

267389000

Equity

871230000

Depreciation

4360000

Change In Working Capital

-287417000

Cash From Operations

29861000

Capital Expenditures

322000

Cash From Investing

-

Cash From Financing

-1289000

Net Change In Cash

28250000

PE

8.3182

PB

1.3051919498295514

ROE

38.80066113425846

ROA

29.68885992592781

FCF

29539000

Fcf Percent

0.059807411186834636

Piotroski FScore

3

Health Score

79

Deep Value Investing Score

9

Defensive Investing Score

7

Dividend Investing Score

3

Economic Moat Investing Score

10

Garp Investing Score

7.5

Growth Investing Score

6

Momentum Investing Score

4

Net Net Investing Score

4.5

Quality Investing Score

10

Value Investing Score

10

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

493902000

Quarters > 0 > income Statement > cost Of Revenue

-21931000

Quarters > 0 > income Statement > gross Profit

472971000

Quarters > 0 > income Statement > operating Expenses

-32612000

Quarters > 0 > income Statement > operating Income

368379000

Quarters > 0 > income Statement > interest Expense

141000

Quarters > 0 > income Statement > pretax Income

370572000

Quarters > 0 > income Statement > net Income

338043000

Quarters > 0 > income Statement > eps

1.5012607053973481

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

225172749

Quarters > 0 > income Statement > income Tax Expense

-32529000

Quarters > 0 > income Statement > EBITDA

-

Quarters > 0 > income Statement > operating Margin

74.58544407595029

Quarters > 0 > income Statement > total Other Income Expense Net

-35377000

Quarters > 0 > balance Sheet > cash

416090000

Quarters > 0 > balance Sheet > short Term Investments

3123000

Quarters > 0 > balance Sheet > receivables

19599000

Quarters > 0 > balance Sheet > inventories

541000

Quarters > 0 > balance Sheet > total Current Assets

873111000

Quarters > 0 > balance Sheet > property Plant Equipment

235603000

Quarters > 0 > balance Sheet > total Assets

1138619000

Quarters > 0 > balance Sheet > payables

8715000

Quarters > 0 > balance Sheet > short Term Debt

-

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

267389000

Quarters > 0 > balance Sheet > equity

871230000

Quarters > 0 > cash Flow > net Income

273229000

Quarters > 0 > cash Flow > depreciation

4360000

Quarters > 0 > cash Flow > change In Working Capital

-287417000

Quarters > 0 > cash Flow > cash From Operations

29861000

Quarters > 0 > cash Flow > capital Expenditures

322000

Quarters > 0 > cash Flow > cash From Investing

-

Quarters > 0 > cash Flow > cash From Financing

-1289000

Quarters > 0 > cash Flow > net Change In Cash

28250000

Quarters > 0 > ratios > PE

1.5012607053973481

Quarters > 0 > ratios > PB

1.3051919498295514

Quarters > 0 > ratios > ROE

38.80066113425846

Quarters > 0 > ratios > ROA

29.68885992592781

Quarters > 0 > ratios > FCF

29539000

Quarters > 0 > ratios > Piotroski FScore

3

Quarters > 0 > ratios > fcf Percent

0.059807411186834636

Quarters > 0 > health Score

79

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

1245000

Quarters > 1 > income Statement > cost Of Revenue

2213000

Quarters > 1 > income Statement > gross Profit

-968000

Quarters > 1 > income Statement > operating Expenses

60778000

Quarters > 1 > income Statement > operating Income

-61746000

Quarters > 1 > income Statement > interest Expense

565000

Quarters > 1 > income Statement > pretax Income

-59966000

Quarters > 1 > income Statement > net Income

-59560000

Quarters > 1 > income Statement > eps

-0.26450791378056343

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

225172847

Quarters > 1 > income Statement > income Tax Expense

-406000

Quarters > 1 > income Statement > EBITDA

-54993000

Quarters > 1 > income Statement > operating Margin

-4959.518072289157

Quarters > 1 > income Statement > total Other Income Expense Net

1780000

Quarters > 1 > balance Sheet > cash

392703000

Quarters > 1 > balance Sheet > short Term Investments

3111000

Quarters > 1 > balance Sheet > receivables

7702000

Quarters > 1 > balance Sheet > inventories

541000

Quarters > 1 > balance Sheet > total Current Assets

419777000

Quarters > 1 > balance Sheet > property Plant Equipment

238411000

Quarters > 1 > balance Sheet > total Assets

688880000

Quarters > 1 > balance Sheet > payables

7581000

Quarters > 1 > balance Sheet > short Term Debt

4885000

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

102513000

Quarters > 1 > balance Sheet > equity

586367000

Quarters > 1 > cash Flow > net Income

-59966000

Quarters > 1 > cash Flow > depreciation

4408000

Quarters > 1 > cash Flow > change In Working Capital

12476000

Quarters > 1 > cash Flow > cash From Operations

-42062000

Quarters > 1 > cash Flow > capital Expenditures

1555000

Quarters > 1 > cash Flow > cash From Investing

-1555000

Quarters > 1 > cash Flow > cash From Financing

-1309000

Quarters > 1 > cash Flow > net Change In Cash

-45628000

Quarters > 1 > ratios > PE

-0.26450791378056343

Quarters > 1 > ratios > PB

1.9392682012289233

Quarters > 1 > ratios > ROE

-10.15746111223858

Quarters > 1 > ratios > ROA

-8.645918011845314

Quarters > 1 > ratios > FCF

-43617000

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-35.033734939759036

Quarters > 1 > health Score

35

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

893000

Quarters > 2 > income Statement > cost Of Revenue

875000

Quarters > 2 > income Statement > gross Profit

18000

Quarters > 2 > income Statement > operating Expenses

54745000

Quarters > 2 > income Statement > operating Income

-54727000

Quarters > 2 > income Statement > interest Expense

333000

Quarters > 2 > income Statement > pretax Income

-51655000

Quarters > 2 > income Statement > net Income

-52084000

Quarters > 2 > income Statement > eps

-0.23132987599010454

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

225150339

Quarters > 2 > income Statement > income Tax Expense

429000

Quarters > 2 > income Statement > EBITDA

-46745000

Quarters > 2 > income Statement > operating Margin

-6128.443449048153

Quarters > 2 > income Statement > total Other Income Expense Net

3072000

Quarters > 2 > balance Sheet > cash

438331000

Quarters > 2 > balance Sheet > short Term Investments

3756000

Quarters > 2 > balance Sheet > receivables

10764000

Quarters > 2 > balance Sheet > inventories

541000

Quarters > 2 > balance Sheet > total Current Assets

469100000

Quarters > 2 > balance Sheet > property Plant Equipment

240986000

Quarters > 2 > balance Sheet > total Assets

742267000

Quarters > 2 > balance Sheet > payables

9428000

Quarters > 2 > balance Sheet > short Term Debt

5198000

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

95578000

Quarters > 2 > balance Sheet > equity

646689000

Quarters > 2 > cash Flow > net Income

-51655000

Quarters > 2 > cash Flow > depreciation

4577000

Quarters > 2 > cash Flow > change In Working Capital

5814000

Quarters > 2 > cash Flow > cash From Operations

-41374000

Quarters > 2 > cash Flow > capital Expenditures

511000

Quarters > 2 > cash Flow > cash From Investing

-511000

Quarters > 2 > cash Flow > cash From Financing

-1312000

Quarters > 2 > cash Flow > net Change In Cash

-43417000

Quarters > 2 > ratios > PE

-0.23132987599010454

Quarters > 2 > ratios > PB

1.7582009465910196

Quarters > 2 > ratios > ROE

-8.053948652288813

Quarters > 2 > ratios > ROA

-7.016882065348453

Quarters > 2 > ratios > FCF

-41885000

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-46.9036954087346

Quarters > 2 > health Score

35

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

14469000

Quarters > 3 > income Statement > cost Of Revenue

1486000

Quarters > 3 > income Statement > gross Profit

12983000

Quarters > 3 > income Statement > operating Expenses

55457000

Quarters > 3 > income Statement > operating Income

-40988000

Quarters > 3 > income Statement > interest Expense

636000

Quarters > 3 > income Statement > pretax Income

-38561000

Quarters > 3 > income Statement > net Income

-32761000

Quarters > 3 > income Statement > eps

-0.14603394195043604

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

224338257

Quarters > 3 > income Statement > income Tax Expense

-

Quarters > 3 > income Statement > EBITDA

-

Quarters > 3 > income Statement > operating Margin

-283.281498375838

Quarters > 3 > income Statement > total Other Income Expense Net

-1932000

Quarters > 3 > balance Sheet > cash

481748000

Quarters > 3 > balance Sheet > short Term Investments

3622000

Quarters > 3 > balance Sheet > receivables

14077000

Quarters > 3 > balance Sheet > inventories

541000

Quarters > 3 > balance Sheet > total Current Assets

526414000

Quarters > 3 > balance Sheet > property Plant Equipment

244652000

Quarters > 3 > balance Sheet > total Assets

802827000

Quarters > 3 > balance Sheet > payables

17272000

Quarters > 3 > balance Sheet > short Term Debt

-

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

106219000

Quarters > 3 > balance Sheet > equity

696608000

Quarters > 3 > cash Flow > net Income

-32761000

Quarters > 3 > cash Flow > depreciation

4304000

Quarters > 3 > cash Flow > change In Working Capital

-50093000

Quarters > 3 > cash Flow > cash From Operations

-66562000

Quarters > 3 > cash Flow > capital Expenditures

2570000

Quarters > 3 > cash Flow > cash From Investing

-

Quarters > 3 > cash Flow > cash From Financing

-1279000

Quarters > 3 > cash Flow > net Change In Cash

-70411000

Quarters > 3 > ratios > PE

-0.14603394195043604

Quarters > 3 > ratios > PB

1.6263209693974228

Quarters > 3 > ratios > ROE

-4.702931921539804

Quarters > 3 > ratios > ROA

-4.080704809379854

Quarters > 3 > ratios > FCF

-69132000

Quarters > 3 > ratios > Piotroski FScore

0

Quarters > 3 > ratios > fcf Percent

-4.777939042089986

Quarters > 3 > health Score

34

Valuation > metrics > PE

8.3182

Valuation > metrics > PB

1.3051919498295514

Valuation > final Score

100

Valuation > verdict

8.4% Undervalued

Profitability > metrics > ROE

38.80066113425846

Profitability > metrics > ROA

38.7170703381357

Profitability > metrics > Net Margin

0.68443334912594

Profitability > final Score

100

Profitability > verdict

Adequate

Risk > metrics > Debt Equity

0.3069097712429554

Risk > metrics > Interest Coverage

2612.6170212765956

Risk > final Score

100

Risk > verdict

Low

Liquidity > metrics > Current Ratio

100.18485370051636

Liquidity > metrics > Quick Ratio

100.122776821572

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

80

Prev Valuations > 1

80

Prev Valuations > 2

80

Prev Profitabilities > 0

0

Prev Profitabilities > 1

0

Prev Profitabilities > 2

0

Prev Risks > 0

-377

Prev Risks > 1

-597

Prev Risks > 2

-198

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-14T00:22:35.376Z